These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 18162774)
1. Diagnostic utility of S100P and von Hippel-Lindau gene product (pVHL) in pancreatic adenocarcinoma-with implication of their roles in early tumorigenesis. Lin F; Shi J; Liu H; Hull ME; Dupree W; Prichard JW; Brown RE; Zhang J; Wang HL; Schuerch C Am J Surg Pathol; 2008 Jan; 32(1):78-91. PubMed ID: 18162774 [TBL] [Abstract][Full Text] [Related]
2. Expression of von Hippel-Lindau gene product (pVHL) and S100P in cystic neoplasms of the pancreas--with an implication for their roles in tumorigenesis. Liu H; Shi J; Wang HL; Zhang J; Brown RE; Wilkerson M; Lin F Ann Clin Lab Sci; 2012; 42(2):109-17. PubMed ID: 22585604 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma. Lok T; Chen L; Lin F; Wang HL Hum Pathol; 2014 Feb; 45(2):394-400. PubMed ID: 24439226 [TBL] [Abstract][Full Text] [Related]
4. S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy. Levy M; Lin F; Xu H; Dhall D; Spaulding BO; Wang HL Hum Pathol; 2010 Sep; 41(9):1210-9. PubMed ID: 20382408 [TBL] [Abstract][Full Text] [Related]
5. Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas. Liu H; Shi J; Anandan V; Wang HL; Diehl D; Blansfield J; Gerhard G; Lin F Arch Pathol Lab Med; 2012 Jun; 136(6):601-9. PubMed ID: 22646265 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of von Hippel-Lindau gene product, maspin, IMP3, and S100P in adenocarcinoma of the gallbladder. Shi J; Liu H; Wang HL; Prichard JW; Lin F Hum Pathol; 2013 Apr; 44(4):503-11. PubMed ID: 23079206 [TBL] [Abstract][Full Text] [Related]
7. Utility of pVHL, maspin, IMP3, S100P and Ki67 in the distinction of autoimmune pancreatitis from pancreatic ductal adenocarcinoma. Hedegaard Jensen G; Mortensen MB; Klöppel G; Nielsen MFB; Nielsen O; Detlefsen S Pathol Res Pract; 2020 May; 216(5):152925. PubMed ID: 32273198 [TBL] [Abstract][Full Text] [Related]
8. Use of IMP3, S100P, and pVHL immunopanel to aid in the interpretation of bile duct biopsies with atypical histology or suspicious for malignancy. Schmidt MT; Himmelfarb EA; Shafi H; Lin F; Xu H; Wang HL Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):478-87. PubMed ID: 22495381 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic Value of S100p, IMP3, Maspin, and pVHL in the Differantial Diagnosis of Pancreatic Ductal Adenocarcinoma and Normal/chronic Pancreatitis in Fine Needle Aspiration Biopsy. Aksoy-Altinboga A; Baglan T; Umudum H; Ceyhan K J Cytol; 2018; 35(4):247-251. PubMed ID: 30498299 [TBL] [Abstract][Full Text] [Related]
10. Survivin expression in pancreatic intraepithelial neoplasia (PanIN): steady increase along the developmental stages of pancreatic ductal adenocarcinoma. Bhanot U; Heydrich R; Möller P; Hasel C Am J Surg Pathol; 2006 Jun; 30(6):754-9. PubMed ID: 16723855 [TBL] [Abstract][Full Text] [Related]
11. Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer. Dowen SE; Crnogorac-Jurcevic T; Gangeswaran R; Hansen M; Eloranta JJ; Bhakta V; Brentnall TA; Lüttges J; Klöppel G; Lemoine NR Am J Pathol; 2005 Jan; 166(1):81-92. PubMed ID: 15632002 [TBL] [Abstract][Full Text] [Related]
12. EGFR expression in pancreatic intraepithelial neoplasia and ductal adenocarcinoma. Park SJ; Gu MJ; Lee DS; Yun SS; Kim HJ; Choi JH Int J Clin Exp Pathol; 2015; 8(7):8298-304. PubMed ID: 26339400 [TBL] [Abstract][Full Text] [Related]
13. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia. Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261 [TBL] [Abstract][Full Text] [Related]
14. The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target. Ohuchida K; Mizumoto K; Ishikawa N; Fujii K; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M Clin Cancer Res; 2005 Nov; 11(21):7785-93. PubMed ID: 16278400 [TBL] [Abstract][Full Text] [Related]
15. High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients. Vimalachandran D; Greenhalf W; Thompson C; Lüttges J; Prime W; Campbell F; Dodson A; Watson R; Crnogorac-Jurcevic T; Lemoine N; Neoptolemos J; Costello E Cancer Res; 2005 Apr; 65(8):3218-25. PubMed ID: 15833853 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of S100P in diagnosis of adenocarcinoma of pancreas on fine-needle aspiration biopsy specimens. Deng H; Shi J; Wilkerson M; Meschter S; Dupree W; Lin F Am J Clin Pathol; 2008 Jan; 129(1):81-8. PubMed ID: 18089492 [TBL] [Abstract][Full Text] [Related]
17. The expression of S100A4 in human pancreatic cancer is associated with invasion. Tsukamoto N; Egawa S; Akada M; Abe K; Saiki Y; Kaneko N; Yokoyama S; Shima K; Yamamura A; Motoi F; Abe H; Hayashi H; Ishida K; Moriya T; Tabata T; Kondo E; Kanai N; Gu Z; Sunamura M; Unno M; Horii A Pancreas; 2013 Aug; 42(6):1027-33. PubMed ID: 23851436 [TBL] [Abstract][Full Text] [Related]
18. Expression of S100 protein family members in normal skin and sweat gland tumors. Zhu L; Okano S; Takahara M; Chiba T; Tu Y; Oda Y; Furue M J Dermatol Sci; 2013 Jun; 70(3):211-9. PubMed ID: 23623205 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Rosty C; Ueki T; Argani P; Jansen M; Yeo CJ; Cameron JL; Hruban RH; Goggins M Am J Pathol; 2002 Jan; 160(1):45-50. PubMed ID: 11786397 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of maspin in distinguishing adenocarcinoma from benign biliary epithelium on endoscopic bile duct biopsy. Chen L; Huang K; Himmelfarb EA; Zhai J; Lai JP; Lin F; Wang HL Hum Pathol; 2015 Nov; 46(11):1647-54. PubMed ID: 26362203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]